EquityZen Growth Technology Fund LLC - Series 1303
Raised
$175K
Investors
7
Min Invest
$10,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1303 is a Delaware-based pooled investment vehicle filed by EquityZen Advisors on 2022-04-27, raising $175K from 7 investors under Rule 506(b) and Section 3(c)(1) exemptions. The offering has a $10K minimum investment and is part of EquityZen's platform of over 1,800 pre-IPO access SPVs targeting secondary shares in private growth companies.
This pre-IPO pooled fund uses the standard 506(b)/3(c)(1) exemption structure common to retail-accessible private investment platforms, with a $10K minimum placing it in the lower tier for accredited investor access. The filing reflects EquityZen's series-based SPV model, where each series typically targets a single underlying company's shares.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.